BioXcel Therapeutics Inc

-0.07 (-1.80%)
5:00:04 PM EDT: $3.86 +0.04 (+1.05%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)111.82M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.76 Million
Adjusted EPS-$0.91
See more estimates
10-Day MA$3.93
50-Day MA$3.50
200-Day MA$12.87
See more pivots

BioXcel Therapeutics Inc Stock, NASDAQ:BTAI

555 Long Wharf Drive, 12th floor, New Haven, Connecticut 06511
United States of America
Phone: +1.475.238.6837
Number of Employees: 183


BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in developing artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology. It also focuses on utilizing cutting-edge technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.